The Promise of Targeted Radiopharmaceuticals in Oncology
Targeted radiopharmaceuticals represent the newest advance in cancer radiotherapy, combining a targeting molecule, linker, chelator and radionuclide to deliver radiation directly to tumor cells while sparing healthy tissue. Recent therapies have shown major clinical gains over standard treatments in neuroendocrine and prostate cancers, alongside rapid commercial growth. For more info: https://www.zs.com/insights/targeted-radiopharmaceuticals
The Promise of Targeted Radiopharmaceuticals in OncologyTargeted radiopharmaceuticals represent the newest advance in cancer radiotherapy, combining a targeting molecule, linker, chelator and radionuclide to deliver radiation directly to tumor cells while sparing healthy tissue. Recent therapies have shown major clinical gains over standard treatments in neuroendocrine and prostate cancers, alongside rapid commercial growth. For more info: https://www.zs.com/insights/targeted-radiopharmaceuticals
0 Комментарии
0 Поделились
35 Просмотры
0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek